These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2305175)

  • 1. In vitro and in vivo effects of three bismuth compounds on fermentation by colonic bacteria.
    León-Barúa R; Tello R; Morante MC; Alvarez M; Gilman RH; Spira WM
    Rev Infect Dis; 1990; 12 Suppl 1():S24-9. PubMed ID: 2305175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].
    León-Barúa R; Tello-Casanova R
    Acta Gastroenterol Latinoam; 1985; 15(3):157-64. PubMed ID: 3836544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The high fermentative capacity of colonic bacteria in the origin of flatulence and its sensibility to bismuth subsalicylate].
    León-Barúa R; Alvarez De Roig M; Roig-Arosemena J; Berendson-Seminario R; Torres-Zevallos H
    Rev Gastroenterol Peru; 2007; 27(1):21-4. PubMed ID: 17431432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
    Healy DP; Dansereau RJ; Dunn AB; Clendening CE; Mounts AW; Deepe GS
    Ann Pharmacother; 1997 Dec; 31(12):1460-4. PubMed ID: 9416381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon.
    Suarez FL; Furne JK; Springfield J; Levitt MD
    Gastroenterology; 1998 May; 114(5):923-9. PubMed ID: 9558280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of one-day oral dosing with three bismuth compounds for the suppression of Helicobacter pylori assessed by the 13C-urea breath test.
    Prewett EJ; Luk YW; Fraser AG; Lam WM; Pounder RE
    Aliment Pharmacol Ther; 1992 Feb; 6(1):97-102. PubMed ID: 1543820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate-reducing bacteria in the rat.
    Ohge H; Furne JK; Springfield J; Sueda T; Madoff RD; Levitt MD
    FEMS Microbiol Lett; 2003 Nov; 228(1):137-42. PubMed ID: 14612249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bismuth subsalicylate on fecal microflora.
    Gorbach SL; Cornick NA; Silva M
    Rev Infect Dis; 1990; 12 Suppl 1():S21-3. PubMed ID: 2305174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of bismuth subsalicylate.
    Cornick NA; Silva M; Gorbach SL
    Rev Infect Dis; 1990; 12 Suppl 1():S9-10. PubMed ID: 2305178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
    Clark CK; Merritt AM; Burrow JA; Steible CK
    J Am Vet Med Assoc; 1996 May; 208(10):1687-91. PubMed ID: 8641951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.
    Manhart MD
    Rev Infect Dis; 1990; 12 Suppl 1():S11-5. PubMed ID: 2406851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
    Rambout L; Sahai J; Gallicano K; Oliveras L; Garber G
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2187-90. PubMed ID: 7811043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro effect of 10 antimicrobial agents on the fermentative capacity of the intestinal bacteria].
    Morante-Bedoya MC; León-Barúa R
    Acta Gastroenterol Latinoam; 1987; 16(4):249-60. PubMed ID: 3425173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.
    Gump DW; Nadeau OW; Hendricks GM; Meyer DH
    Med Microbiol Immunol; 1992; 181(3):131-43. PubMed ID: 1522823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid.
    Kappstein I; Engels I
    Eur J Clin Microbiol; 1987 Apr; 6(2):216-7. PubMed ID: 3595590
    [No Abstract]   [Full Text] [Related]  

  • 17. Site of bismuth absorption from bismuth subsalicylate: implications for treatment of colonic conditions.
    Suarez FL; Furne J; Stiehm J; Garten C; Levitt MD
    Dig Dis Sci; 2000 Jul; 45(7):1444-6. PubMed ID: 10961727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of subsalicylate bismuth on absorption of doxycycline.
    Ericsson CD; Feldman S; Pickering LK; Cleary TG
    JAMA; 1982 Apr; 247(16):2266-7. PubMed ID: 7040708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.
    Bravo LE; Realpe JL; Campo C; Mera R; Correa P
    Am J Gastroenterol; 1999 Sep; 94(9):2380-3. PubMed ID: 10483995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of bismuth-containing compounds.
    Lambert JR
    Rev Infect Dis; 1991; 13 Suppl 8():S691-5. PubMed ID: 1925310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.